Weekly Recap | Twist Bioscience -16.92%, AI drug-discovery sentiment coolsWeekly Review·Oct 17, 2026 at 08:22 AMTWST+1.93%
Weekly Recap | Twist Bioscience -15.31%, most brokers rate it buyWeekly Review·Oct 10, 2026 at 08:06 AMTWST+1.93%
Weekly Recap | Twist Bioscience +3.19%, consensus target below spotWeekly Review·Oct 3, 2026 at 08:40 AMTWST+1.93%
Weekly Recap | Twist Bioscience +9.49%, closing in on record highsWeekly Review·Sep 26, 2026 at 07:14 AMTWST+1.93%
Weekly Recap | Twist Bioscience +31.26%, signs deal with Lilly TuneLabWeekly Review·Sep 19, 2026 at 06:54 AMTWST+1.93%
Weekly Recap | Twist Bioscience +2%, consensus target below spotWeekly Review·Sep 12, 2026 at 07:00 AMTWST+1.93%
Weekly Recap | Twist Bioscience -11.78%, giving back prior gainsWeekly Review·Sep 5, 2026 at 08:18 AMTWST+1.93%
Weekly Recap | Twist Bioscience -2.89%, most brokers rate it buyWeekly Review·Aug 29, 2026 at 06:36 AMTWST+1.93%
Weekly Recap | Twist Bioscience +22.79%, AI deal sparks 52-week highWeekly Review·Aug 22, 2026 at 05:41 AMTWST+1.93%
